Daniel Dale Kenneth Lingwood, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Influenza Vaccines | 13 | 2024 | 780 | 2.560 |
Why?
|
Receptors, Antigen, B-Cell | 9 | 2023 | 546 | 2.550 |
Why?
|
Influenza A virus | 6 | 2024 | 455 | 2.420 |
Why?
|
Influenza, Human | 14 | 2025 | 1543 | 1.790 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 11 | 2025 | 163 | 1.730 |
Why?
|
Membrane Microdomains | 7 | 2014 | 205 | 1.670 |
Why?
|
Antibodies, Neutralizing | 17 | 2024 | 2010 | 1.540 |
Why?
|
B-Lymphocytes | 14 | 2025 | 4784 | 1.350 |
Why?
|
Antibodies, Viral | 18 | 2025 | 3212 | 1.350 |
Why?
|
AIDS Vaccines | 4 | 2024 | 898 | 1.120 |
Why?
|
Vaccines, Virus-Like Particle | 2 | 2024 | 44 | 0.970 |
Why?
|
Cell Membrane | 5 | 2014 | 3641 | 0.820 |
Why?
|
Orthomyxoviridae Infections | 2 | 2024 | 255 | 0.800 |
Why?
|
RNA Phages | 1 | 2021 | 3 | 0.780 |
Why?
|
Gills | 3 | 2006 | 22 | 0.760 |
Why?
|
Protein Engineering | 2 | 2021 | 554 | 0.710 |
Why?
|
Immunoglobulin Variable Region | 2 | 2024 | 419 | 0.700 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 3 | 2006 | 479 | 0.610 |
Why?
|
Orthomyxoviridae | 2 | 2024 | 148 | 0.570 |
Why?
|
Immunity, Humoral | 7 | 2024 | 608 | 0.550 |
Why?
|
Vaccination | 6 | 2024 | 3434 | 0.530 |
Why?
|
Galactosylceramides | 2 | 2006 | 90 | 0.500 |
Why?
|
Mice, Transgenic | 6 | 2024 | 9547 | 0.480 |
Why?
|
Germinal Center | 4 | 2022 | 379 | 0.480 |
Why?
|
Sperm Capacitation | 1 | 2014 | 21 | 0.470 |
Why?
|
Antigens | 5 | 2022 | 1441 | 0.470 |
Why?
|
Carbohydrates | 1 | 2016 | 387 | 0.470 |
Why?
|
Epitopes | 9 | 2024 | 2526 | 0.460 |
Why?
|
Lipocalins | 1 | 2014 | 160 | 0.440 |
Why?
|
Acute-Phase Proteins | 1 | 2014 | 251 | 0.430 |
Why?
|
Allosteric Regulation | 1 | 2014 | 425 | 0.420 |
Why?
|
HIV Antigens | 3 | 2024 | 328 | 0.420 |
Why?
|
Cholesterol | 7 | 2011 | 2903 | 0.410 |
Why?
|
Lipopolysaccharides | 1 | 2020 | 2214 | 0.410 |
Why?
|
Influenza A Virus, H5N1 Subtype | 4 | 2025 | 117 | 0.390 |
Why?
|
Sphingolipids | 3 | 2010 | 177 | 0.380 |
Why?
|
Membrane Lipids | 2 | 2009 | 241 | 0.370 |
Why?
|
Detergents | 3 | 2010 | 235 | 0.360 |
Why?
|
Eukaryota | 1 | 2011 | 101 | 0.360 |
Why?
|
Interleukin-6 | 1 | 2020 | 3227 | 0.360 |
Why?
|
Oncogene Proteins | 1 | 2014 | 715 | 0.350 |
Why?
|
Glycolipids | 1 | 2011 | 203 | 0.350 |
Why?
|
Dendritic Cells | 2 | 2020 | 2747 | 0.340 |
Why?
|
Virus Internalization | 3 | 2022 | 504 | 0.340 |
Why?
|
Complementarity Determining Regions | 4 | 2024 | 154 | 0.340 |
Why?
|
Lipid Bilayers | 5 | 2011 | 376 | 0.320 |
Why?
|
Immunoglobulin Heavy Chains | 3 | 2019 | 647 | 0.310 |
Why?
|
Oncorhynchus mykiss | 2 | 2005 | 19 | 0.300 |
Why?
|
Seawater | 2 | 2005 | 126 | 0.290 |
Why?
|
Mice | 20 | 2024 | 81889 | 0.290 |
Why?
|
Animals | 30 | 2025 | 168930 | 0.290 |
Why?
|
Vaccines | 1 | 2016 | 842 | 0.280 |
Why?
|
Antibody Formation | 2 | 2024 | 1392 | 0.270 |
Why?
|
Cross Reactions | 4 | 2024 | 826 | 0.270 |
Why?
|
Membrane Proteins | 8 | 2020 | 7868 | 0.270 |
Why?
|
Cell Fractionation | 1 | 2007 | 245 | 0.270 |
Why?
|
Endoplasmic Reticulum | 2 | 2009 | 1132 | 0.260 |
Why?
|
Antibody Affinity | 2 | 2019 | 251 | 0.250 |
Why?
|
HIV Envelope Protein gp120 | 3 | 2024 | 923 | 0.240 |
Why?
|
Acclimatization | 1 | 2005 | 113 | 0.240 |
Why?
|
Antigens, Viral | 4 | 2022 | 995 | 0.240 |
Why?
|
Sulfoglycosphingolipids | 1 | 2004 | 32 | 0.240 |
Why?
|
Models, Biological | 4 | 2014 | 9461 | 0.230 |
Why?
|
Polysaccharides | 3 | 2022 | 1020 | 0.230 |
Why?
|
Immunoglobulin M | 3 | 2020 | 1527 | 0.230 |
Why?
|
Antibody Specificity | 2 | 2021 | 1062 | 0.220 |
Why?
|
Mannose-Binding Lectin | 2 | 2022 | 146 | 0.220 |
Why?
|
Immunoenzyme Techniques | 1 | 2006 | 1697 | 0.210 |
Why?
|
Fishes | 1 | 2006 | 607 | 0.210 |
Why?
|
Alkaline Phosphatase | 1 | 2006 | 855 | 0.210 |
Why?
|
Immunoglobulins | 1 | 2006 | 853 | 0.200 |
Why?
|
HIV Infections | 4 | 2024 | 17536 | 0.200 |
Why?
|
Coronavirus | 2 | 2021 | 155 | 0.200 |
Why?
|
Phospholipids | 1 | 2006 | 778 | 0.200 |
Why?
|
Ligands | 3 | 2022 | 3275 | 0.190 |
Why?
|
Saponins | 1 | 2021 | 47 | 0.190 |
Why?
|
Lymph | 1 | 2021 | 78 | 0.190 |
Why?
|
Receptors, Cell Surface | 1 | 2011 | 2815 | 0.190 |
Why?
|
Autophagy | 1 | 2009 | 1346 | 0.190 |
Why?
|
Fresh Water | 3 | 2006 | 82 | 0.190 |
Why?
|
Alleles | 2 | 2022 | 6895 | 0.180 |
Why?
|
Influenza A Virus, H1N1 Subtype | 2 | 2025 | 453 | 0.180 |
Why?
|
Recombinant Proteins | 2 | 2015 | 6507 | 0.180 |
Why?
|
Bacteria | 1 | 2011 | 2212 | 0.180 |
Why?
|
HIV-1 | 4 | 2024 | 6948 | 0.170 |
Why?
|
Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase | 1 | 2020 | 26 | 0.170 |
Why?
|
Humans | 44 | 2025 | 766766 | 0.170 |
Why?
|
Amino Acid Substitution | 1 | 2024 | 1742 | 0.160 |
Why?
|
Toll-Like Receptor 7 | 1 | 2020 | 169 | 0.160 |
Why?
|
Receptors, Interleukin-6 | 1 | 2020 | 227 | 0.160 |
Why?
|
Interferon Regulatory Factors | 1 | 2020 | 272 | 0.160 |
Why?
|
Signal Transduction | 3 | 2020 | 23619 | 0.160 |
Why?
|
Lentivirus | 1 | 2022 | 518 | 0.160 |
Why?
|
Cell Line | 5 | 2020 | 15563 | 0.160 |
Why?
|
Adoptive Transfer | 1 | 2021 | 828 | 0.160 |
Why?
|
Epitope Mapping | 1 | 2019 | 301 | 0.160 |
Why?
|
Enterocytes | 1 | 2020 | 220 | 0.160 |
Why?
|
Gene Library | 1 | 2021 | 1065 | 0.150 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 326 | 0.150 |
Why?
|
Homeostasis | 1 | 2009 | 3342 | 0.150 |
Why?
|
Viral Envelope Proteins | 1 | 2022 | 640 | 0.150 |
Why?
|
Toll-Like Receptors | 1 | 2021 | 582 | 0.150 |
Why?
|
Immunoconjugates | 1 | 2006 | 976 | 0.150 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2023 | 366 | 0.150 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 2022 | 812 | 0.150 |
Why?
|
Nanoparticles | 5 | 2022 | 1966 | 0.150 |
Why?
|
Molecular Sequence Data | 6 | 2015 | 17608 | 0.140 |
Why?
|
Adaptation, Physiological | 1 | 2004 | 1313 | 0.140 |
Why?
|
Amino Acid Sequence | 5 | 2015 | 13411 | 0.140 |
Why?
|
Plasma Cells | 1 | 2020 | 599 | 0.140 |
Why?
|
Toll-Like Receptor 4 | 1 | 2020 | 588 | 0.140 |
Why?
|
Goblet Cells | 1 | 2020 | 300 | 0.140 |
Why?
|
Immunization, Secondary | 1 | 2019 | 372 | 0.140 |
Why?
|
Nasal Mucosa | 1 | 2020 | 416 | 0.140 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2022 | 2571 | 0.130 |
Why?
|
Adaptive Immunity | 1 | 2021 | 734 | 0.130 |
Why?
|
Adjuvants, Immunologic | 1 | 2021 | 996 | 0.130 |
Why?
|
Interferon Type I | 1 | 2020 | 568 | 0.130 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2022 | 1362 | 0.120 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2020 | 975 | 0.120 |
Why?
|
Gangliosidosis, GM1 | 1 | 2014 | 11 | 0.120 |
Why?
|
HIV Antibodies | 4 | 2024 | 1337 | 0.120 |
Why?
|
Single-Chain Antibodies | 1 | 2015 | 114 | 0.120 |
Why?
|
Single-Cell Analysis | 3 | 2022 | 2534 | 0.120 |
Why?
|
Models, Molecular | 4 | 2015 | 5386 | 0.110 |
Why?
|
Basement Membrane | 2 | 2005 | 348 | 0.110 |
Why?
|
Water-Electrolyte Balance | 2 | 2005 | 326 | 0.110 |
Why?
|
Liposomes | 2 | 2018 | 787 | 0.100 |
Why?
|
Binding Sites, Antibody | 1 | 2012 | 340 | 0.100 |
Why?
|
Sequence Alignment | 2 | 2015 | 2177 | 0.100 |
Why?
|
Sperm Maturation | 1 | 2011 | 22 | 0.090 |
Why?
|
Host-Pathogen Interactions | 1 | 2020 | 1466 | 0.090 |
Why?
|
Germ-Line Mutation | 1 | 2019 | 1885 | 0.090 |
Why?
|
Mice, Inbred BALB C | 4 | 2022 | 6222 | 0.090 |
Why?
|
Drug Delivery Systems | 1 | 2022 | 2210 | 0.090 |
Why?
|
Mice, Inbred C57BL | 4 | 2022 | 22352 | 0.090 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2011 | 391 | 0.090 |
Why?
|
Lipoylation | 1 | 2010 | 87 | 0.090 |
Why?
|
Membrane Glycoproteins | 1 | 2020 | 3702 | 0.080 |
Why?
|
Molecular Conformation | 1 | 2011 | 540 | 0.080 |
Why?
|
Spectrometry, Fluorescence | 2 | 2009 | 694 | 0.080 |
Why?
|
Vaccines, Inactivated | 2 | 2024 | 186 | 0.080 |
Why?
|
Epitopes, B-Lymphocyte | 2 | 2022 | 84 | 0.080 |
Why?
|
Chromatography, Thin Layer | 2 | 2006 | 211 | 0.080 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4780 | 0.080 |
Why?
|
Immunologic Memory | 1 | 2015 | 1377 | 0.080 |
Why?
|
Phase Transition | 1 | 2008 | 70 | 0.080 |
Why?
|
Immunoglobulin G | 3 | 2020 | 4559 | 0.080 |
Why?
|
G(M1) Ganglioside | 1 | 2008 | 87 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4652 | 0.070 |
Why?
|
Organelles | 1 | 2009 | 265 | 0.070 |
Why?
|
Complement System Proteins | 2 | 2022 | 738 | 0.070 |
Why?
|
Receptors, Transferrin | 1 | 2008 | 300 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2018 | 3077 | 0.070 |
Why?
|
Diffusion | 1 | 2008 | 808 | 0.070 |
Why?
|
Polysorbates | 1 | 2006 | 46 | 0.070 |
Why?
|
Micelles | 1 | 2007 | 190 | 0.060 |
Why?
|
Horseradish Peroxidase | 1 | 2006 | 169 | 0.060 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3110 | 0.060 |
Why?
|
Cholera Toxin | 1 | 2008 | 562 | 0.060 |
Why?
|
Cerebroside-Sulfatase | 1 | 2005 | 15 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2020 | 2902 | 0.060 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3232 | 0.060 |
Why?
|
Protein Multimerization | 1 | 2010 | 960 | 0.060 |
Why?
|
Solubility | 1 | 2007 | 1078 | 0.060 |
Why?
|
Protein Binding | 2 | 2016 | 9320 | 0.060 |
Why?
|
Protein Conformation | 1 | 2012 | 3947 | 0.060 |
Why?
|
Levivirus | 1 | 2024 | 14 | 0.060 |
Why?
|
Macaca mulatta | 2 | 2021 | 2341 | 0.060 |
Why?
|
Biological Evolution | 1 | 2010 | 1075 | 0.060 |
Why?
|
Immunodominant Epitopes | 1 | 2024 | 244 | 0.050 |
Why?
|
Microtubule-Associated Proteins | 1 | 2009 | 1071 | 0.050 |
Why?
|
Hemagglutinins | 1 | 2024 | 111 | 0.050 |
Why?
|
Osmolar Concentration | 1 | 2004 | 655 | 0.050 |
Why?
|
Antibodies, Blocking | 1 | 2024 | 250 | 0.050 |
Why?
|
Rats | 3 | 2021 | 23717 | 0.050 |
Why?
|
Cell Differentiation | 1 | 2020 | 11651 | 0.050 |
Why?
|
Shiga Toxins | 1 | 2002 | 39 | 0.050 |
Why?
|
Trihexosylceramides | 1 | 2002 | 29 | 0.050 |
Why?
|
HeLa Cells | 1 | 2009 | 3073 | 0.050 |
Why?
|
Protein Processing, Post-Translational | 1 | 2010 | 1964 | 0.050 |
Why?
|
Vaccines, Attenuated | 1 | 2024 | 314 | 0.050 |
Why?
|
Amino Acid Motifs | 1 | 2024 | 928 | 0.050 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2023 | 168 | 0.050 |
Why?
|
Phosphoproteins | 1 | 2010 | 2448 | 0.050 |
Why?
|
Mannose | 1 | 2022 | 121 | 0.050 |
Why?
|
Erythrocytes | 1 | 2011 | 2412 | 0.050 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 1 | 2024 | 381 | 0.050 |
Why?
|
Inflammation | 1 | 2020 | 10860 | 0.050 |
Why?
|
Epithelium | 1 | 2005 | 1606 | 0.040 |
Why?
|
Germ Cells | 1 | 2024 | 645 | 0.040 |
Why?
|
Biology | 1 | 2022 | 292 | 0.040 |
Why?
|
Dibenzothiepins | 1 | 2020 | 8 | 0.040 |
Why?
|
Thiepins | 1 | 2020 | 5 | 0.040 |
Why?
|
Fluorescent Dyes | 1 | 2008 | 1927 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 1 | 2020 | 190 | 0.040 |
Why?
|
Cell Culture Techniques | 1 | 2007 | 1646 | 0.040 |
Why?
|
Complement Fixation Tests | 1 | 2018 | 67 | 0.040 |
Why?
|
Peptide Fragments | 1 | 2011 | 5143 | 0.040 |
Why?
|
Glycosylation | 1 | 2022 | 1099 | 0.040 |
Why?
|
Lipids | 1 | 2009 | 3319 | 0.040 |
Why?
|
HIV Seropositivity | 1 | 2024 | 962 | 0.040 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2020 | 196 | 0.040 |
Why?
|
Bacterial Proteins | 1 | 2011 | 3833 | 0.040 |
Why?
|
Receptors, Complement | 1 | 2018 | 254 | 0.040 |
Why?
|
Female | 8 | 2022 | 396520 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 18075 | 0.040 |
Why?
|
Triazines | 1 | 2020 | 311 | 0.040 |
Why?
|
Seasons | 1 | 2024 | 1521 | 0.040 |
Why?
|
Amino Acids | 1 | 2024 | 1711 | 0.040 |
Why?
|
Rats, Wistar | 1 | 2021 | 1889 | 0.040 |
Why?
|
Oxazines | 1 | 2020 | 358 | 0.040 |
Why?
|
Antibodies, Monoclonal | 2 | 2025 | 9244 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 3804 | 0.030 |
Why?
|
Immunoglobulin A | 1 | 2020 | 992 | 0.030 |
Why?
|
Methyltransferases | 1 | 2020 | 373 | 0.030 |
Why?
|
Morpholines | 1 | 2020 | 584 | 0.030 |
Why?
|
Receptors, Virus | 1 | 2020 | 652 | 0.030 |
Why?
|
Gastrointestinal Tract | 1 | 2022 | 834 | 0.030 |
Why?
|
Male | 5 | 2022 | 364142 | 0.030 |
Why?
|
Feces | 1 | 2022 | 1505 | 0.030 |
Why?
|
Ferrets | 1 | 2015 | 181 | 0.030 |
Why?
|
Serine Endopeptidases | 1 | 2020 | 1027 | 0.030 |
Why?
|
Antibodies | 1 | 2022 | 2421 | 0.030 |
Why?
|
Pyridones | 1 | 2020 | 818 | 0.030 |
Why?
|
Spleen | 1 | 2020 | 2295 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2020 | 18984 | 0.030 |
Why?
|
Killer Cells, Natural | 1 | 2023 | 2210 | 0.030 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 938 | 0.030 |
Why?
|
Vaccines, DNA | 1 | 2015 | 279 | 0.030 |
Why?
|
RNA, Viral | 1 | 2022 | 2867 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2018 | 1110 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4142 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2021 | 5503 | 0.020 |
Why?
|
Peptides | 1 | 2022 | 4344 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2019 | 4276 | 0.020 |
Why?
|
Pandemics | 2 | 2020 | 8735 | 0.020 |
Why?
|
DNA | 1 | 2024 | 7208 | 0.020 |
Why?
|
Laurates | 1 | 2009 | 7 | 0.020 |
Why?
|
2-Naphthylamine | 1 | 2009 | 20 | 0.020 |
Why?
|
Mycobacterium tuberculosis | 1 | 2020 | 1911 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2021 | 4410 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2020 | 4349 | 0.020 |
Why?
|
Molecular Dynamics Simulation | 1 | 2011 | 423 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10100 | 0.020 |
Why?
|
Pyridines | 1 | 2020 | 2888 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8891 | 0.020 |
Why?
|
Antiviral Agents | 1 | 2020 | 3070 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2019 | 3666 | 0.020 |
Why?
|
Tuberculosis | 1 | 2020 | 2011 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2020 | 4400 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5923 | 0.020 |
Why?
|
Immunotherapy | 1 | 2022 | 4747 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10580 | 0.020 |
Why?
|
Genetic Loci | 1 | 2015 | 2630 | 0.020 |
Why?
|
Cytokines | 1 | 2020 | 7438 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2014 | 5890 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15908 | 0.010 |
Why?
|
Hydroxylation | 1 | 2002 | 139 | 0.010 |
Why?
|
Lung | 1 | 2020 | 10067 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18330 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2020 | 12806 | 0.010 |
Why?
|
Aged | 2 | 2023 | 171343 | 0.010 |
Why?
|
Models, Theoretical | 1 | 2009 | 3561 | 0.010 |
Why?
|
Middle Aged | 2 | 2020 | 223257 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2020 | 59550 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2010 | 17088 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2020 | 65273 | 0.010 |
Why?
|
Child | 1 | 2020 | 80668 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 88904 | 0.010 |
Why?
|
Adult | 1 | 2020 | 223307 | 0.000 |
Why?
|